Advertisement
"The ACC requires high standards of service coupled with the marketintelligence and research to help us compete most effectively," said JackLewin, CEO of the ACC. "Elsevier's collective knowledge, experience,reputation and commitment to publishing quality, plus their vision in helpingus launch two new journals in a very competitive market place led us tohappily renew this agreement as a long term partnership.
Advertisement
Elsevier has published JACC since its inception in 1983. Publishedweekly, JACC has the highest readership (according to PERQ/HCI research),largest circulation and second highest impact factor (11.054) in itsspecialty. JACC articles were cited nearly 53,000 times in 2007 and full textarticle downloads via ACCs CardioSource and Elsevier's ScienceDirect exceeded6.4 million. An additional 17,000 articles were downloaded for free indeveloping regions of the world during 2008 through the Research4Life(formerly HINARI) (http://www.research4life.org) information philanthropyprogram run by the United Nations.
"The ACC has been publishing with Elsevier for more than two decades aspart of a mutually beneficial relationship neither side has ever taken forgranted," said Glen P. Campbell, Senior Vice President and head of Elsevier'sUS Health Sciences Journals. "Our knowledge of the information needs of boththe clinical and academic communities and the excellent reach ofScienceDirect in providing access to the worldwide research community placeus in a unique position to help advance and promote the interests of oursociety partners."
The ACC is the world's largest cardiology society with 37,000 members.The College is a leader in the formulation of health policy, standards andguidelines, and is a staunch supporter of cardiovascular research. The ACCalso bestows the credential Fellow of the American College of Cardiology uponphysicians who meet its stringent qualifications, provides professionaleducation and operates national registries for the measurement andimprovement of quality care.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical andmedical information products and services. Working in partnership with theglobal science and health communities, Elsevier's 7,000 employees in over 70offices worldwide publish more than 2,000 journals and 1,900 new books peryear, in addition to offering a suite of innovative electronic products, suchas ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered inAmsterdam, The Netherlands and has offices worldwide. Elsevier is part ofReed Elsevier Group plc (http://www.reedelsevier.com/), a world-leadingpublisher and information provider. Operating in the science and medical,legal, education and business-to-business sectors, Reed Elsevier provideshigh-quality and flexible information solutions to users, with increasingemphasis on the Internet as a means of delivery. Reed Elsevier's tickersymbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK andENL (New York Stock Exchange).Contact: Tom Reller +1-212-462-1912 [email protected]
SOURCE Elsevier
